TMCnet News
Vertex Pharmaceuticals (VRTX) Downgrade Alert, Watch for 8.4% Technical Uptrend ReversalNov 17, 2009 (SmarTrend(R) Spotlight via COMTEX) -- Vertex Pharmaceuticals (NASDAQ:VRTX) downgraded to Neutral from Buy, $32-39 target, at Merriman. The stock closed yesterday at $40.50 on volume of 2,560,800 shares, above average daily volume of 1,907,525. Vertex Pharmaceuticals is currently above its 50-day moving average of $35.99 and above its 200-day moving average of $32.76. SmarTrend is bullish on shares of VRTX and our subscribers received an Uptrend alert on November 02, 2009 at $37.35, which has returned 8.4% to date. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com. Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html |
